Bloodstream Infections Caused by Enterobacter Species: Predictors of 30-Day Mortality Rate and Impact of Broad-Spectrum Cephalosporin Resistance on Outcome
Clinical Infectious Diseases2004Vol. 39(6), pp. 812–818
Citations Over TimeTop 15% of 2004 papers
Cheol‐In Kang, Sun‐Hyun Kim, Wan Beom Park, K.-D. Lee, Hong Bin Kim, Myoung‐don Oh, E.-C. Kim, Kang Won Choe
Abstract
Broad-spectrum cephalosporin resistance adversely affects the outcome of patients with Enterobacter bacteremia, especially those with an unknown primary site of infection and those with septic shock.
Related Papers
- → Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients(2004)7 cited
- [Interaction of cyclosporine in the microbiological assay of cefotaxime and ceftazidime. Interaction of cefotaxime and ceftazidime in the radioimmunological assay of cyclosporine].(1987)
- Antibacterial Effect of Cephalothin on ESBLs-producing K.Pneunmoniae(2006)
- A clinical study on the effects of ceftazidime and cefotaxime on neonatal septicemia(2003)
- [Analysis of susceptibility of bacteria isolated from clinical material to cefuroxime, ceftazidime and cefotaxime].(1993)